Neoadjuvant chemotherapy for advanced ovarian cancer was initially administered as an alternative treatment for patients not suitable for primary debulking surgery (PDS) because of unresectable ...
Traditionally, chemotherapy was given after surgery (primary cytoreductive surgery (PCRS) and adjuvant chemotherapy). However, chemotherapy can be used before surgery (neoadjuvant chemotherapy (NACT) ...
Primary debulking surgery for advanced epithelial ovarian cancer with isolated enlarged para-aortic lymph node by robotic transumbilical single port approach. Low pressure laparoscopic procedure ...
Opportunistic salpingectomy (OS) during any suitable abdominal surgery is effective for reducing the incidence of ovari ...
AI models outperform traditional statistics in predicting post-complete cytoreduction outcomes in ovarian cancer patients ... application in predicting debulking outcomes. Despite these challenges ...
"If I did not proceed with this surgery, my cancer would not have been discovered when it was." Paolone was shocked by her ...